Kalvista Non Current Liabilities Other from 2010 to 2025

KALV Stock  USD 11.93  0.41  3.32%   
Kalvista Pharmaceuticals Non Current Liabilities Other yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Other will likely drop to about 5.2 M in 2025. During the period from 2010 to 2025, Kalvista Pharmaceuticals Non Current Liabilities Other regression line of quarterly data had mean square error of 2.2 T and geometric mean of  4,005,667. View All Fundamentals
 
Non Current Liabilities Other  
First Reported
2015-01-31
Previous Quarter
7.4 M
Current Value
7.1 M
Quarterly Volatility
2.7 M
 
Yuan Drop
 
Covid
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 985.3 K, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Latest Kalvista Pharmaceuticals' Non Current Liabilities Other Growth Pattern

Below is the plot of the Non Current Liabilities Other of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Other10 Years Trend
Slightly volatile
   Non Current Liabilities Other   
       Timeline  

Kalvista Non Current Liabilities Other Regression Statistics

Arithmetic Mean4,445,936
Geometric Mean4,005,667
Coefficient Of Variation44.94
Mean Deviation1,665,545
Median3,342,000
Standard Deviation1,997,867
Sample Variance4T
Range7.2M
R-Value0.69
Mean Square Error2.2T
R-Squared0.47
Significance0
Slope289,107
Total Sum of Squares59.9T

Kalvista Non Current Liabilities Other History

20255.2 M
20248.2 M
20227.1 M
20217.2 M
2020M
20191.1 M

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Other8.2 M5.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.